Fig. 3
From: Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
Prognostic model based on Nomogram to foresee the survival of BRCA patients. A Forest plot summary of univariate regression analyses of riskScore and clinicopathological characteristics in TCGA-BRCA cohort. B Forest plot summary of multivariate regression analyses of riskScore and clinicopathological characteristics in TCGA-BRCA cohort. C Nomograms for predicting the probability of patient mortality at 1-,3- or 5-year OS based on riskScore. D Calibration curves of the nomogram for predicting the probability of OS at 1-,3-, and 5-years